Kezar Life Sciences, Inc.

NASDAQ:KZR

0.5826 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Operating Activities:
Net Income -101.87-68.239-54.63-41.742-35.087-23.167-8.517-8.99
Depreciation & Amortization 1.0661.0231.511.5441.3010.690.1750.154
Deferred Income Tax -6.34701.7700000
Stock Based Compensation 18.13714.0067.5964.9434.0071.9930.2030.128
Change In Working Capital 4.706-4.4591.226-2.0110.8810.0620.03-1.052
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables 6.3471.8141.2170.3132.2081.440.081-0.469
Other Working Capital -1.641-6.2730.009-2.324-1.327-1.378-0.051-0.583
Other Non Cash Items 2.663-1.1770.0910.317-0.979-0.370.4720.979
Operating Cash Flow -81.645-58.846-42.437-36.949-29.877-20.792-8.109-9.76
Investing Activities:
Investments In Property Plant And Equipment -1.81-1.578-0.316-0.194-0.607-1.12-0.389-0.132
Acquisitions Net 0.0050.090.0280.056-0.0210.0100
Purchases Of Investments -180.399-332.203-156.378-225.728-102.255-119.24400
Sales Maturities Of Investments 258.25242.389128.25169.424123.28136.4500
Other Investing Activites 77.856-0.09-0.028-0.0560.0210.0100
Investing Cash Flow 76.046-91.392-28.444-56.49820.419-83.904-0.389-0.132
Financing Activities:
Debt Repayment 00-9.53100000
Common Stock Issued 0.638127.861103.05499.6420.27277.69549.7550.036
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 0.638127.86119.06299.6420.2720.21849.7550.036
Financing Cash Flow 0.638127.861112.58599.6420.27277.91349.7550.036
Other Information:
Effect Of Forex Changes On Cash -0.002-0.049-0.050.082-0.045-0.0810.029-0.15
Net Change In Cash -4.963-22.42641.6546.277-9.231-26.86441.286-10.006
Cash At End Of Period 35.49340.45662.88221.22814.95124.18251.0469.76